{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:48:36Z","timestamp":1791884916999,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bvth.2026.100219","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:09:22Z","timestamp":1789574962000},"page":"100219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and economic impact of rFVIIa prophylaxis in Glanzmann thrombasthenia: cohort analysis in Saudi Arabia"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0032-7479","authenticated-orcid":false,"given":"Ahmad","family":"Tarawah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3601-1919","authenticated-orcid":false,"given":"Sami","family":"Albattat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Shahba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1294-8005","authenticated-orcid":false,"given":"Mohamed","family":"Nashat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3489-368X","authenticated-orcid":false,"given":"Sarah","family":"Brighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Back","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7642-6849","authenticated-orcid":false,"given":"Sam","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2014-3415","authenticated-orcid":false,"given":"George","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bvth.2026.100219_bib1","series-title":"Congenital Bleeding Disorder","first-page":"379","article-title":"Glanzmann thrombasthenia: diagnosis and management","author":"Poon","year":"2023"},{"issue":"2","key":"10.1016\/j.bvth.2026.100219_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12308-020-00421-9","article-title":"Acquired Glanzmann thrombasthenia: a rare disorder","volume":"14","author":"Padate","year":"2021","journal-title":"J Hematop"},{"key":"10.1016\/j.bvth.2026.100219_bib3","series-title":"Encyclopedia of Molecular Mechanisms of Disease","first-page":"701","article-title":"Glanzmann\u2019s Thrombasthenia","author":"Timson","year":"2009"},{"key":"10.1016\/j.bvth.2026.100219_bib4","first-page":"289","article-title":"Disease burden in patients with Glanzmann\u2019s thrombasthenia: perspectives from the Glanzmann\u2019s Thrombasthenia Patient\/Caregiver Questionnaire","volume":"11","author":"Duncan","year":"2020","journal-title":"J Blood Med"},{"issue":"1","key":"10.1016\/j.bvth.2026.100219_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/hae.70170","article-title":"Characterising Glanzmann thrombasthenia in the United States: real-world data from the EPIC cosmos dataset","volume":"32","author":"Citla-Sridhar","year":"2026","journal-title":"Haemophilia"},{"key":"10.1016\/j.bvth.2026.100219_bib6","series-title":"Clinical history and management of Glanzmann thrombasthenia: a retrospective chart review","author":"Morgan","year":"2025"},{"key":"10.1016\/j.bvth.2026.100219_bib7","series-title":"Impact of iron deficiency anaemia & heavy menstrual bleeding in Glanzmann thrombasthenia","author":"Morgan","year":"2025"},{"key":"10.1016\/j.bvth.2026.100219_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/JBM.S271744","article-title":"Glanzmann thrombasthenia: perspectives from clinical practice on accurate diagnosis and optimal treatment strategies","volume":"12","author":"Mathews","year":"2021","journal-title":"J Blood Med"},{"issue":"1","key":"10.1016\/j.bvth.2026.100219_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13023-023-02787-2","article-title":"Emergency management of patients with Glanzmann thrombasthenia: consensus recommendations from the French reference center for inherited platelet disorders","volume":"18","author":"Fiore","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.bvth.2026.100219_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/2040620717737701","article-title":"Recombinant human factor VIIa (rFVIIa) in hemophilia: mode of action and evidence to date","volume":"8","author":"Giansily-Blaizot","year":"2017","journal-title":"Ther Adv Hematol"},{"issue":"5","key":"10.1016\/j.bvth.2026.100219_bib11","first-page":"655","article-title":"Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann\u2019s thrombasthenia","volume":"3","author":"Poon","year":"2007","journal-title":"Vasc Health Risk Manag"},{"issue":"4","key":"10.1016\/j.bvth.2026.100219_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/hae.14559","article-title":"Iron deficiency anemia and bleeding management in pediatric patients with Bernard-Soulier syndrome and Glanzmann thrombasthenia: a single-institution analysis","volume":"28","author":"Lee","year":"2022","journal-title":"Haemophilia"},{"issue":"suppl 1","key":"10.1016\/j.bvth.2026.100219_bib13","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1182\/blood-2018-99-119403","article-title":"Bleeding severity and health care utilization in patients with platelet function disorders","volume":"132","author":"Citla Sridhar","year":"2018","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.bvth.2026.100219_bib14","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1182\/blood-2024-199031","article-title":"Evaluating the burden of Glanzmann thrombasthenia: a systematic literature review to identify research priorities","volume":"144","author":"Morgan","year":"2024","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bvth.2026.100219_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2024.10.3522","article-title":"PCR280 a systematic literature review of the research upon the burden, quality of life, and economic cost impact of Glanzmann thrombasthenia","volume":"27","author":"Morgan","year":"2024","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.bvth.2026.100219_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/hae.15130","article-title":"Efficacy and safety of recombinant activated factor VII in Glanzmann thrombasthenia: a systematic literature review","volume":"31","author":"Saultier","year":"2025","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.bvth.2026.100219_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12288-013-0240-9","article-title":"Rational use of recombinant factor VIIa in clinical practice","volume":"30","author":"Dutta","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"10.1016\/j.bvth.2026.100219_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2516.2008.01969.x","article-title":"A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor\/moderate bleeding episodes for haemophilia patients with inhibitors","volume":"15","author":"Knight","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.bvth.2026.100219_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2377-8-17","article-title":"Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage","volume":"8","author":"Kissela","year":"2008","journal-title":"BMC Neurol"},{"issue":"2","key":"10.1016\/j.bvth.2026.100219_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.36401\/JQSH-19-41","article-title":"Medication-use evaluation of recombinant human factor VIIa","volume":"3","author":"Al-Subhi","year":"2020","journal-title":"Glob J Qual Saf Healthc"},{"key":"10.1016\/j.bvth.2026.100219_bib21","series-title":"Uncovering the cost of red blood cell (RBC) and platelet (PLT) transfusions in Africa, Asia, Oceania, and the Americas and exploring related implications in a trial example","author":"Molinari","year":"2025"},{"issue":"1","key":"10.1016\/j.bvth.2026.100219_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.sjbs.2020.10.055","article-title":"Development of unit cost for the health services offered at King FAHD Central Hospital Jazan, Saudi Arabia","volume":"28","author":"Ghilan","year":"2021","journal-title":"Saudi J Biol Sci"},{"issue":"8","key":"10.1016\/j.bvth.2026.100219_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/17474086.2018.1489719","article-title":"The benefits of prophylaxis in patients with hemophilia B","volume":"11","author":"Castaman","year":"2018","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.bvth.2026.100219_bib24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1160\/TH11-03-0193","article-title":"Haemophilia B: impact on patients and economic burden of disease","volume":"106","author":"Gater","year":"2011","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.bvth.2026.100219_bib25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1365-2516.2008.01843.x","article-title":"A survey of adherence to haemophilia therapy in six European countries: results and recommendations","volume":"14","author":"De Moerloose","year":"2008","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.bvth.2026.100219_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tmrv.2016.01.001","article-title":"New insights into the treatment of Glanzmann thrombasthenia","volume":"30","author":"Poon","year":"2016","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.bvth.2026.100219_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/joah.joah_68_18","article-title":"Management of Glanzmann\u2019s thrombasthenia\u2013guidelines based on an expert panel consensus from Gulf Cooperation Council countries","volume":"10","author":"Tarawah","year":"2019","journal-title":"J Appl Hematol"},{"key":"10.1016\/j.bvth.2026.100219_bib28","series-title":"Population Estimates Publication 2024","year":"2024"},{"issue":"6","key":"10.1016\/j.bvth.2026.100219_bib29","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/hae.15126","article-title":"One day at a time: life with Glanzmann thrombasthenia \u2013 qualitative results from the GT 360 study","volume":"30","author":"Khair","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.bvth.2026.100219_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/JBM.S71319","article-title":"Glanzmann\u2019s thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options","volume":"6","author":"Solh","year":"2015","journal-title":"J Blood Med"},{"issue":"7","key":"10.1016\/j.bvth.2026.100219_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102586","article-title":"Bleeding and quality of life in people with Glanzmann thrombasthenia\u2014insights from the Glanzmann\u2019s 360 study","volume":"8","author":"Khair","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"10.1016\/j.bvth.2026.100219_bib32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40801-024-00452-z","article-title":"Evaluating the effectiveness of prophylactic strategies for hemophilia A management: a real-world, longitudinal observational study","volume":"11","author":"Chiou","year":"2024","journal-title":"Drugs Real World Outcomes"},{"issue":"1","key":"10.1016\/j.bvth.2026.100219_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13023-022-02300-1","article-title":"Differential humanistic and economic burden of mild, moderate and severe haemophilia in European adults: a regression analysis of the CHESS II study","volume":"17","author":"Rodriguez-Santana","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.bvth.2026.100219_bib34","first-page":"e117","article-title":"Relationship between bleeding episodes, health-related quality of life and direct costs in adults with severe haemophilia A: secondary analyses from the CHESS study","volume":"28","author":"O\u2019Hara","year":"2022","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.bvth.2026.100219_bib35","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/bjh.70056","article-title":"Management of pregnancy and childbirth in Glanzmann thrombasthenia: a case series and review","volume":"207","author":"Rutten","year":"2025","journal-title":"Br J Haematol"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:25:39Z","timestamp":1791883539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2950327226000847"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100219","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and economic impact of rFVIIa prophylaxis in Glanzmann thrombasthenia: cohort analysis in Saudi Arabia","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100219"}}